☆ 4.6 Article

YAP1 Expression in HR+HER2-Breast Cancer: 21-Gene Recurrence Score Analysis and Public Dataset Validation

CANCERS (2023)

Related references

Note: Only part of the references are listed.

Article Radiology, Nuclear Medicine & Medical Imaging

Shear-wave elastography-based nomograms predicting 21-gene recurrence score for adjuvant chemotherapy decisions in patients with breast cancer

Ji Hyun Youk et al.

Summary: The purpose of this study was to develop and validate nomograms using shear-wave elastography (SWE) and clinicopathologic features to predict Oncotype DX recurrence score (RS) for guiding adjuvant systemic therapy decisions. In a retrospective study, patients who underwent breast cancer surgery between August 2011 and December 2019 were divided into a development set and an independent validation set. Logistic regression was used to assess clinicopathologic features and SWE elasticity indices in order to develop nomograms for predicting RS >= 16 and >= 26. The performance of the nomograms was evaluated using the area under the receiver operating characteristic curve (AUROC).

EUROPEAN JOURNAL OF RADIOLOGY (2023)

Add to Collection

Article Oncology

Feasibility of Shear Wave Elastography Imaging for Evaluating the Biological Behavior of Breast Cancer

Chaoxu Liu et al.

Summary: The study suggests that shear wave elastography (SWE) parameters, including E-max, SD, and AR, can be used to evaluate the biological behavior of breast cancer. There is no significant association between SWE parameters and pathological type or histopathological classification, but an increase in histological grade of invasive ductal carcinoma is associated with increased SD and S-max values. SWE parameters are also related to ALN status, LVI status, ER and PR expression, HER2 status, and Ki-67 expression. Ki-67, ER, and LVI are independent influencing factors of SWE parameters.

FRONTIERS IN ONCOLOGY (2022)

Add to Collection

Article Biochemistry & Molecular Biology

Knockdown of YAP/TAZ sensitizes tamoxifen-resistant MCF7 breast cancer cells

Yu Jin Kim et al.

Summary: Targeting the YAP/TAZ-PSAT1 axis can sensitize tamoxifen-resistant MCF7 breast cancer cells by modulating the mTORC1-survivin axis.

BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2022)

Add to Collection

Article Oncology

Association of breast cancer risk, density, and stiffness: global tissue stiffness on breast MR elastography (MRE)

Bhavika K. Patel et al.

Summary: This study aims to quantify the biomechanical properties of breast tissue in different densities and risk levels using MRI/MRE and examine their association with breast cancer risk based on patient demographics and clinical data.

BREAST CANCER RESEARCH AND TREATMENT (2022)

Add to Collection

Article Multidisciplinary Sciences

Transcriptional repression of estrogen receptor alpha by YAP reveals the Hippo pathway as therapeutic target for ER+ breast cancer

Shenghong Ma et al.

Summary: This study reveals the involvement of Hippo signalling in the transcriptional repression of ESR1 and its impact on ER+ breast cancer. The inhibition of LATS can effectively repress ESR1 expression and inhibit the growth of ER+ breast cancer cells. The findings highlight LATS as a potential therapeutic target for endocrine-resistant breast cancers.

NATURE COMMUNICATIONS (2022)

Add to Collection

Article Oncology

The Value of Shear Wave Elastography in the Diagnosis of Breast Cancer Axillary Lymph Node Metastasis and Its Correlation With Molecular Classification of Breast Masses

Changyun Luo et al.

Summary: The study demonstrates the high diagnostic value of SWE examination in axillary node metastasis of breast cancer, as it can be used as a routine auxiliary method of CUE. There were no significant differences in elastic modulus values among different molecular types of breast cancer.

FRONTIERS IN ONCOLOGY (2022)

Add to Collection

Article Oncology

Correlation of Yes-Associated Protein 1 with Stroma Type and Tumor Stiffness in Hormone-Receptor Positive Breast Cancer

Yangkyu Lee et al.

Summary: This study confirmed the correlation between nuclear YAP1 expression and tumor stiffness and identified nuclear YAP1 expression as a prognostic candidate in HR+ tumors based on shear-wave elastography-measured tumor stiffness.

CANCERS (2022)

Add to Collection

Review Oncology

The clinical significance of HER2 expression in DCIS

Ioanna Akrida et al.

Summary: HER2 plays a prognostic and predictive role in patients with invasive breast cancer, but its significance in DCIS patients is unclear. HER2-positive DCIS cases may be associated with adverse clinicopathological parameters and increased recurrence rates.

MEDICAL ONCOLOGY (2022)

Add to Collection

Article Oncology

Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries

Hyuna Sung et al.

Summary: The global cancer burden in 2020 saw an estimated 19.3 million new cancer cases and almost 10.0 million cancer deaths. Female breast cancer surpassed lung cancer as the most commonly diagnosed cancer, while lung cancer remained the leading cause of cancer death. These trends are expected to rise in 2040, with transitioning countries experiencing a larger increase compared to transitioned countries due to demographic changes and risk factors associated with globalization and a growing economy. Efforts to improve cancer prevention measures and provision of cancer care in transitioning countries will be crucial for global cancer control.

CA-A CANCER JOURNAL FOR CLINICIANS (2021)

Add to Collection

Letter Multidisciplinary Sciences

Hippo signalling maintains ER expression and ER+ breast cancer growth

Shenghong Ma et al.

NATURE (2021)

Add to Collection

Article Pathology

Relationship of Oncotype Dx score with tumor grade, size, nodal status, proliferative marker Ki67 and Nottingham Prognostic Index in early breast cancer tumors in Saudi Population

Sajid Durrani et al.

Summary: The study investigated the relationship between Oncotype Dx and pathological prognostic markers in breast cancer patients, finding a significant correlation between high grade tumors and high Ki67 levels with Oncotype Dx score, while age, tumor size, and nodal status showed no significant association with Oncotype Dx score.

ANNALS OF DIAGNOSTIC PATHOLOGY (2021)

Add to Collection

Article Cell Biology

YAP, CTGF and Cyr61 are overexpressed in tamoxifen-resistant breast cancer and induce transcriptional repression of ERα

Hyungjoo Kim et al.

Summary: The study found that in tamoxifen-resistant breast cancer, YAP, CTGF, and Cyr61 are overexpressed while ER alpha is downregulated. Inhibition of YAP, CTGF, and Cyr61 can restore ER alpha expression and increase sensitivity to tamoxifen. CTGF and Cyr61 downregulate ER alpha expression at the transcriptional level by directly binding to the regulatory regions of the ER alpha-encoding gene, leading to increased tamoxifen resistance.

JOURNAL OF CELL SCIENCE (2021)

Add to Collection

Article Medicine, Research & Experimental

YAP1 is an independent prognostic marker in pancreatic cancer and associated with extracellular matrix remodeling

Qimin Zhou et al.

JOURNAL OF TRANSLATIONAL MEDICINE (2020)

Add to Collection

Article Radiology, Nuclear Medicine & Medical Imaging

Relationship Between Shear Wave Elastography Findings and Histologic Prognostic Factors of Invasive Breast Cancer

Aysegul Akdogan Gemici et al.

ULTRASOUND QUARTERLY (2020)

Add to Collection

Article Biochemistry & Molecular Biology

YAP1 overexpression is associated with poor prognosis of breast cancer patients and induces breast cancer cell growth by inhibiting PTEN

Liwen Guo et al.

FEBS OPEN BIO (2019)

Add to Collection

Article Oncology

OncotypeDX Recurrence Score Does Not Predict Nodal Burden in Clinically Node Negative Breast Cancer Patients

S. E. Tevis et al.

ANNALS OF SURGICAL ONCOLOGY (2019)

Add to Collection

Article Oncology

Lymph Node Status in Breast Cancer Does Not Predict Tumor Biology

Danielle M. Bello et al.

ANNALS OF SURGICAL ONCOLOGY (2018)

Add to Collection

Article Oncology

Human Epidermal Growth Factor Receptor 2 Testing in Breast Cancer: American Society of Clinical Oncology/College of American Pathologists Clinical Practice Guideline Focused Update

Antonio C. Wolff et al.

JOURNAL OF CLINICAL ONCOLOGY (2018)

Add to Collection

Review Oncology

Targeting the tumour stroma to improve cancer therapy

Kenneth C. Valkenburg et al.

NATURE REVIEWS CLINICAL ONCOLOGY (2018)

Add to Collection

Article Medicine, General & Internal

Adjuvant Chemotherapy Guided by a 21-Gene Expression Assay in Breast Cancer

J. A. Sparano et al.

NEW ENGLAND JOURNAL OF MEDICINE (2018)

Add to Collection

Article Oncology

Tumour-stroma ratio and prognosis in gastric adenocarcinoma

Niko Kemi et al.

BRITISH JOURNAL OF CANCER (2018)

Add to Collection

Article Pathology

Expression of YES-associated protein (YAP) and its clinical significance in breast cancer tissues

Lanqing Cao et al.

HUMAN PATHOLOGY (2017)

Add to Collection

Review Oncology

The evaluation of tumor-infiltrating lymphocytes (TILs) in breast cancer: recommendations by an International TILs Working Group 2014

R. Salgado et al.

ANNALS OF ONCOLOGY (2015)

Add to Collection

Article Medicine, Research & Experimental

YAP Expression in Normal and Neoplastic Breast Tissue: An Immunohistochemical Study

Yolanda Jaramillo-Rodriguez et al.

ARCHIVES OF MEDICAL RESEARCH (2014)

Add to Collection

Article Oncology

Decreased expression of Yes-associated protein is associated with outcome in the luminal A breast cancer subgroup and with an impaired tamoxifen response

Sophie Lehn et al.

BMC CANCER (2014)

Add to Collection

Article Acoustics

PREDICTING PROGNOSTIC FACTORS OF BREAST CANCER USING SHEAR WAVE ELASTOGRAPHY

Woo Jung Choi et al.

ULTRASOUND IN MEDICINE AND BIOLOGY (2014)

Add to Collection

Article Oncology

Nuclear localization of the transcriptional coactivator YAP is associated with invasive lobular breast cancer

Eva J. Vlug et al.

CELLULAR ONCOLOGY (2013)

Add to Collection

Article Oncology

YAP is a candidate oncogene for esophageal squamous cell carcinoma

Tomoki Muramatsu et al.

CARCINOGENESIS (2011)

Add to Collection

Article Biochemistry & Molecular Biology

The Hippo pathway transcriptional co-activator, YAP, is an ovarian cancer oncogene

X. Zhang et al.

ONCOGENE (2011)

Add to Collection

Article Oncology

Hippo Pathway Effector Yap Is an Ovarian Cancer Oncogene

Chad A. Hall et al.

CANCER RESEARCH (2010)

Add to Collection

Article Oncology

American Society of Clinical Oncology/College of American Pathologists Guideline Recommendations for Immunohistochemical Testing of Estrogen and Progesterone Receptors in Breast Cancer

M. Elizabeth H. Hammond et al.

JOURNAL OF CLINICAL ONCOLOGY (2010)

Add to Collection

Review Oncology

Biological determinants of endocrine resistance in breast cancer

Elizabeth A. Musgrove et al.

NATURE REVIEWS CANCER (2009)

Add to Collection

Article Biochemistry & Molecular Biology

Yes-associated protein (YAP) functions as a tumor suppressor in breast

M. Yuan et al.

CELL DEATH AND DIFFERENTIATION (2008)

Add to Collection

Article Biochemistry & Molecular Biology

The Hippo signaling pathway coordinately regulates cell proliferation and apoptosis by inactivating Yorkie, the Drosophila homolog of YAP

JB Huang et al.

CELL (2005)

Add to Collection

Article Medicine, General & Internal

A multigene assay to predict recurrence of tamoxifen-treated, node-negative breast cancer

S Paik et al.

NEW ENGLAND JOURNAL OF MEDICINE (2004)

Add to Collection

© Peeref 2019-2024. All rights reserved.